Floatz logo

Sodium Hyaluronate

Dry Eye

Peking University Third HospitalN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Dry Eye cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Barbara Burgos Blasco
Phase 4BBB
Azithromycin
University of California, San Francisco
Phase 4BB
Sodium Hyaluronate
Peking University Third Hospital
Phase 4BB
Insulin Human
Khyber Teaching Hospital
Phase 4BB
VITAMIN D
University of Faisalabad
Phase 3BB

View all 10 →

Same molecule, other indications

Sodium Hyaluronate is also rated in:

dry eye syndromeDormant
BB
Indicative ·
65 / 100
View asset →
diabetes mellitusDormant
BB
Indicative ·
65 / 100
View asset →
background diabetic retinopathyDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →